Newman, J., Seetharamu, N., & Saif, M. W. (2020). Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors. Cancer Med J.
Chicago Style citaatNewman, James, Nagashree Seetharamu, en Muhammad Wasif Saif. "Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors." Cancer Med J 2020.
MLA citatieNewman, James, Nagashree Seetharamu, en Muhammad Wasif Saif. "Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors." Cancer Med J 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.